–
Atrium Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−118
FY22:
−179
FY23:
−6.39
FY24:
−13.2
FY25:
−76.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−117
FY22:
−178
FY23:
−6.25
FY24:
−13.0
FY25:
−76.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−118
FY22:
−174
FY23:
−6.39
FY24:
−13.2
FY25:
−76.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−118
FY22:
−174
FY23:
−6.39
FY24:
−25.1
FY25:
−76.7
All amounts in millions USD